Cefiderocol: a promising antibiotic against multidrug-resistant Gram-negative bacteria | Synapse

⌘+K

Keep reading

Synapse has enriched 10 related papers. Consider them for comparative context:

1Carbapenemase-Producing Gram-Negative Bacteria: Current Epidemics, Antimicrobial Susceptibility and Treatment OptionsOriginal Research · 2015 · 126 citations
2Distribution of ESBLs, AmpC β-lactamases and carbapenemases among Enterobacteriaceae isolates causing intra-abdominal and urinary tract infections in the Asia-Pacific region during 2008–14: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART)Original Research · 2016 · 95 citations
3Global Dissemination of Carbapenemase-Producing Klebsiella pneumoniae: Epidemiology, Genetic Context, Treatment Options, and Detection MethodsRandomized Controlled Trial · 2016 · 752 citations
4Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosisOriginal Research · 2017 · 6,403 citations
5Investigational drugs for the treatment of infections caused by multidrug-resistant Gram-negative bacteriaHuman Clinical Trial · 2018 · 40 citations
6Antibiotic Hybrids: the Next Generation of Agents and Adjuvants against Gram-Negative Pathogens?Review · 2018 · 286 citations
7<i>In vitro</i>activities of cefiderocol, ceftolozane/tazobactam, ceftazidime/avibactam and other comparative drugs against imipenem-resistant<i>Pseudomonas aeruginosa</i>and<i>Acinetobacter baumannii</i>, and<i>Stenotrophomonas maltophilia</i>, all associated with bloodstream infections in TaiwanOriginal Research · 2018 · 107 citations
8Efficacy of Humanized Exposures of Cefiderocol (S-649266) against a Diverse Population of Gram-Negative Bacteria in a Murine Thigh Infection ModelOriginal Research · 2017 · 101 citations
9Rezafungin in clinical practice: current evidence and expert perspectivesExpert Review of Anti-infective Therapy · 2026
10Perspectives from Taiwan: managing comorbidities amongst the Taiwanese population treating HIV with antiretroviral therapyExpert Review of Anti-infective Therapy · 2026

More from Expert Review of Anti-infective Therapy

More from National Taiwan University Hospital